Skip to main content
. 2016 Apr 21;39(4):201–206. doi: 10.1002/clc.22509

Table 1.

Baseline Characteristics of the Study Population

Characteristics Total, N = 286 Nondiabetics, N = 198 Diabetics, N = 88 P Value
Age, y 68.6 ± 10.9 66.6 ± 14.1 70.7 ± 9.5 <0.001
Sex
M 202 (70.6) 138 (69.7) 64 (72.7) 0.60
F 84 (29.4) 60 (30.3) 24 (27.3)
CV risk factors
Arterial hypertension 221 (77.3) 140 (70.7) 81 (92.0) <0.001
Hyperlipidemia 168 (58.7) 104 (52.5) 64 (72.7) 0.001
Renal insufficiency 75 (26.2) 41 (20.7) 34 (38.6) 0.001
Tobacco use 105 (36.7) 71 (35.9) 34 (38.6) 0.65
Family history 55 (19.2) 44 (22.2) 11 (12.5) 0.54
History
ACS 166 (58.0) 113 (57.1) 53 (60.2) 0.62
SAP 120 (42.0) 85 (42.9) 35 (39.8) 0.62
CAD type
1 vessel 62 (21.7) 51 (25.8) 11 (12.5) 0.02
2 vessels 94 (32.9) 57 (28.8) 37 (42.0)
3 vessels 130 (45.5) 90 (45.5) 40 (45.5)
Previous MI 87 (30.4) 57 (28.8) 30 (34.1) 0.37
Medications
ACEIs 177 (61.9) 121 (61.1) 56 (63.6) 0.69
ARBs 36 (12.6) 21 (10.6) 15 (17.0) 0.13
β‐Blockers 214 (74.8) 145 (73.2) 69 (78.4) 0.35
CCBs 48 (16.8) 25 (12.6) 23 (26.1) 0.005
Diuretics 153 (53.5) 101 (51.0) 52 (59.1) 0.21
Statins 140 (49.0) 93 (47.0) 47 (53.4) 0.32
Insulin 28 (9.8) N/A 28 (31.8) <0.0001
Clopidogrel 87 (30.4) 59 (29.8) 28 (31.8) 0.73
ASA 189 (66.1) 126 (63.6) 63 (71.6) 0.19
Laboratory parameters
GFRa, mL/min/1.73 m2 36.7 ± 17.7 40.7 ± 19.7 32.7 ± 15.7 0.010
CRP, mg/L 2.48 ± 3.8 2.06 ± 3.3 2.9 ± 4.2 0.008

Abbreviations: ACEI, angiotensin‐converting enzyme inhibitor; ACS, acute coronary syndrome; ARB, angiotensin receptor blocker; ASA, aspirin; CAD, coronary artery disease; CCB, calcium channel blocker; CRP, C‐reactive protein; CV, cardiovascular; F, female; GFR, glomerular filtration rate; M, male; MI, myocardial infarction; N/A, not applicable; SAP, stable angina pectoris; SD, standard deviation.

Values are given as n (%) or mean ± SD.

a

Calculated according to Modification of Diet in Renal Disease equation.